HE4和CA125在卵巢肿瘤中的应用价值(3)
[Abstract]Objective To establish a simple and effective method of predicting ovarian malignant tumor by the detection of serum human epididymis protein 4 (HE4) and carbohydrate antigen 125 (CA125) of patients with ovarian tumor.Methods Serum HE4 and CA125 levels of 453 patients with ovarian tumor in our hospital from January 2013 to December 2014 were determined by Roche electrochemical luminescence method.Among them，80 patients with ovarian malignant tumor，373 patients with ovarian benign tumors (including 135 cases of ovarian endometriosis cyst，116 cases of ovarian teratoma，45 cases of mucous and serous cystadenoma，51 cases of ovarian simple cyst and 26 cases of corpus luteum cyst).All the results were statistically analysed.Results Comparison of serum HE4 levels between patients with ovarian benign tumor，there was no statistically significant difference (P>0.05)；serum CA125 level of ovarian endometriosis cyst group was higher than that of other groups，the difference was statistically significant (P<0.05)， Comparison between the rest of the group，there was no statistically significant difference (P>0.05).If compared with benign ovarian tumors，serum HE4 cut-off value was 126.2 pmol/L，the clinical diagnosis sensitivity in patients with ovarian malignant tumor was 72.5%.Conclusion HE4 and CA125 are better clinical auxiliary diagnosis indicator of ovarian tumor.
[Key words]Ovarian tumor；Human epididymis protein 4；Carbohydrate antigen 125；Tumor marker (李峰 何华 朱亚飞 江丽霞 王琴)
[Key words]Ovarian tumor；Human epididymis protein 4；Carbohydrate antigen 125；Tumor marker (李峰 何华 朱亚飞 江丽霞 王琴)